Liquid biopsies unlock noninvasive cancer screening and monitoring by analyzing cancer biomarkers in blood, but the signals can be sparse and noisy. Exai Bio has pioneered AI-driven liquid biopsy using novel small RNA biomarkers. In recent work, Exai-1 and Orion – two new generative AI for cell-free RNA – achieve breakthroughs in signal denoising and early cancer detection. These advances were made possible by Databricks’ lakehouse architecture and cloud AI infrastructure.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Amir
Contact Amir, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack